Literature DB >> 8840068

Intrathecal ketorolac tromethamine produces analgesia after chronic constriction injury of sciatic nerve in rat.

W C Parris1, P K Janicki, B Johnson, J L Horn.   

Abstract

PURPOSE: The study compared analgesic efficacy of intrathecally administered ketorolac tromethamine (K) and morphine hydrochloride (M) (in equimolar doses) in the chronic neuropathic pain model, induced by chronic constriction injury (CCI) of the sciatic nerve in rat.
METHODS: Male Sprague-Dawley rats (n = 30) were anaesthetized with halothane and an intrathecal catheter was inserted to the mid-lumbar level of the spinal cord. On the 5th post-operative day, rats were anaesthetized with halothane and four ligatures were loosely applied around the right sciatic nerve. Seven days later, those animals were randomly divided into three groups and were injected with either saline, M (20 nmoles) or K (20 nmoles). Two pain responses (foot-withdrawal delay and hind paw elevation time) were measured on both sides using the radiant heat method. Further, thermal ("cold") allodynia was assessed by measuring of the total time of hind paw elevation in animals placed on the cold metal plate.
RESULTS: Twenty nmoles of M and K injected intrathecally produced decrease of differential pain score calculated for both measured responses (hind paw withdrawal and hind paw elevation), compared with saline injected animals (P < 0.05). The reduction in pain response produced by K was less (P < 0.05). than the reduction in pain response observed in the animals receiving intrathecal M. Measurement of cold allodynia revealed that the animals in M and K injected groups demonstrated decreases in the total hind paw elevation time, when compared with saline-injected animals (P < 0.05).
CONCLUSION: M and K produced hypoalgesia after intrathecal administration in rats with CCI, with M being more potent than K at an equimolar dose range. The analgesic effect of K was equal to equimolar doses of M for alleviation of cold allodynia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8840068     DOI: 10.1007/BF03013041

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  10 in total

1.  Ethical guidelines for investigations of experimental pain in conscious animals.

Authors:  Manfred Zimmermann
Journal:  Pain       Date:  1983-06       Impact factor: 6.961

2.  Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction.

Authors:  A B Malmberg; T L Yaksh
Journal:  Anesthesiology       Date:  1993-08       Impact factor: 7.892

3.  Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition.

Authors:  A B Malmberg; T L Yaksh
Journal:  Science       Date:  1992-08-28       Impact factor: 47.728

4.  Previous administration of indomethacin or naloxone did not influence ketorolac antinociception in mice.

Authors:  H F Miranda; F Sierralta; G Pinardi
Journal:  Anesth Analg       Date:  1993-10       Impact factor: 5.108

5.  Antinociceptive activity of intrathecal ketorolac is blocked by the kappa-opioid receptor antagonist, nor-binaltorphimine.

Authors:  L A Uphouse; S P Welch; C R Ward; E F Ellis; J P Embrey
Journal:  Eur J Pharmacol       Date:  1993-09-21       Impact factor: 4.432

6.  Chronic catheterization of the spinal subarachnoid space.

Authors:  T L Yaksh; T A Rudy
Journal:  Physiol Behav       Date:  1976-12

Review 7.  Clinical pharmacokinetics of ketorolac tromethamine.

Authors:  D R Brocks; F Jamali
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

8.  Nociceptive effects induced by intrathecal administration of prostaglandin D2, E2, or F2 alpha to conscious mice.

Authors:  R Uda; S Horiguchi; S Ito; M Hyodo; O Hayaishi
Journal:  Brain Res       Date:  1990-02-26       Impact factor: 3.252

9.  Ketorolac potentiates morphine antinociception during visceral nociception in the rat.

Authors:  T J Maves; P S Pechman; S T Meller; G F Gebhart
Journal:  Anesthesiology       Date:  1994-05       Impact factor: 7.892

10.  A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man.

Authors:  G J Bennett; Y K Xie
Journal:  Pain       Date:  1988-04       Impact factor: 6.961

  10 in total
  5 in total

1.  Role of spinal cyclooxygenase in human postoperative and chronic pain.

Authors:  James C Eisenach; Regina Curry; Richard Rauck; Peter Pan; Tony L Yaksh
Journal:  Anesthesiology       Date:  2010-05       Impact factor: 7.892

Review 2.  Current and Future Issues in the Development of Spinal Agents for the Management of Pain.

Authors:  Tony L Yaksh; Casey J Fisher; Tyler M Hockman; Ashley J Wiese
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

3.  Recent advances in the treatment of pain.

Authors:  Mellar P Davis
Journal:  F1000 Med Rep       Date:  2010-08-19

4.  Secondary hyperalgesia in the rat first degree burn model is independent of spinal cyclooxygenase and nitric oxide synthase.

Authors:  Linda S Sorkin; Carmen M Doom; Karly P Maruyama; Danielle B Nanigian
Journal:  Eur J Pharmacol       Date:  2008-04-01       Impact factor: 4.432

5.  Co-Administered Low Doses Of Ibuprofen And Dexamethasone Produce Synergistic Antinociceptive Effects On Neuropathic Mechanical Allodynia In Rats.

Authors:  Min K Park; Song H Kang; Jo Y Son; Min K Lee; Jin S Ju; Yong C Bae; Dong K Ahn
Journal:  J Pain Res       Date:  2019-10-30       Impact factor: 3.133

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.